North America Flow Cytometry Market Size, Share & Industry Trends Analysis Report By Application (Academic & Clinical and Diagnostic), By End User, By Technology (Cell Based and Bead Based), By Component, By Country and Growth Forecast, 2022 – 2028
The North America Flow Cytometry Market would witness market growth of 7.8% CAGR during the forecast period (2022-2028).
The standard setup for an experiment starts with fluorescently tagged cells suspended in a single cell, however, any material containing particles can be used. After being placed over the flow cytometer, the specimen is absorbed into the device, where sheath fluid, a physiological buffer, surrounds the cells. The original sample suspension is organized into a single-file sequence of cells by the fluidics system, which consists of the tubing, pumps, and valves, as they move throughout the flow cytometer for examination.
The interrogation point is the location where laser light interacts with the cells. The phrase laser intercept may also be used to describe it. This is where the event occurs. When a single cell is illuminated by a laser beam, some of the light will hit the internal physical components of the cell and disperse. This light scatter may be quantified and associated with internal cell architecture and relative cell size.
The development of technology and its widespread implementation in a variety of research and diagnostics applications are the main drivers of the North American flow cytometry market. Furthermore, it is anticipated that the use of flow cytometric technologies in diagnostic applications will be stimulated by the rising incidence rates of diseases like cancer and HIV. The market's growth rate is also anticipated to be fueled by the strengthening economies of industrialized nations, like the United States and others.
The US market dominated the North America Flow Cytometry Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,042.3 million by 2028. The Canada market is poised to grow at a CAGR of 10.3% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 9.3% during (2022 - 2028).
Based on Application, the market is segmented into Academic & Clinical and Diagnostic. Based on End User, the market is segmented into Commercial Organizations, Hospitals, Academic Institutions, Medical Schools & Clinical Testing Labs, and Others. Based on Technology, the market is segmented into Cell Based and Bead Based. Based on Component, the market is segmented into Instruments, Reagents & Consumables, Software, and Services. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, BioMérieux S.A., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Miltenyi Biotec B.V. & Co. KG, Sartorius AG, and Sysmex Corporation.
Scope of the Study
Market Segments covered in the Report:
By Application
- Academic & Clinical
- Diagnostic
- Commercial Organizations
- Hospitals
- Academic Institutions
- Medical Schools & Clinical Testing Labs
- Others
- Cell Based
- Bead Based
- Instruments
- Reagents & Consumables
- Software
- Services
- US
- Canada
- Mexico
- Rest of North America
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Becton Dickinson and Company
- BioMérieux S.A.
- Bio-Rad Laboratories, Inc.
- DiaSorin S.p.A.
- Miltenyi Biotec B.V. & Co. KG
- Sartorius AG
- Sysmex Corporation
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Flow Cytometry Market, by Application
- 1.4.2 North America Flow Cytometry Market, by End User
- 1.4.3 North America Flow Cytometry Market, by Technology
- 1.4.4 North America Flow Cytometry Market, by Component
- 1.4.5 North America Flow Cytometry Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market composition and scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.2.4 Acquisition and Mergers
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
- Chapter 4. North America Flow Cytometry Market by Application
- 4.1 North America Academic & Clinical Market by Country
- 4.2 North America Diagnostic Market by Country
- Chapter 5. North America Flow Cytometry Market by End User
- 5.1 North America Commercial Organizations Market by Country
- 5.2 North America Hospitals Market by Country
- 5.3 North America Academic Institutions Market by Country
- 5.4 North America Medical Schools & Clinical Testing Labs Market by Country
- 5.5 North America Other End User Market by Country
- Chapter 6. North America Flow Cytometry Market by Technology
- 6.1 North America Cell Based Market by Country
- 6.2 North America Bead Based Market by Country
- Chapter 7. North America Flow Cytometry Market by Component
- 7.1 North America Instruments Market by Country
- 7.2 North America Reagents & Consumables Market by Country
- 7.3 North America Software Market by Country
- 7.4 North America Services Market by Country
- Chapter 8. North America Flow Cytometry Market by Country
- 8.1 US Flow Cytometry Market
- 8.1.1 US Flow Cytometry Market by Application
- 8.1.2 US Flow Cytometry Market by End User
- 8.1.3 US Flow Cytometry Market by Technology
- 8.1.4 US Flow Cytometry Market by Component
- 8.2 Canada Flow Cytometry Market
- 8.2.1 Canada Flow Cytometry Market by Application
- 8.2.2 Canada Flow Cytometry Market by End User
- 8.2.3 Canada Flow Cytometry Market by Technology
- 8.2.4 Canada Flow Cytometry Market by Component
- 8.3 Mexico Flow Cytometry Market
- 8.3.1 Mexico Flow Cytometry Market by Application
- 8.3.2 Mexico Flow Cytometry Market by End User
- 8.3.3 Mexico Flow Cytometry Market by Technology
- 8.3.4 Mexico Flow Cytometry Market by Component
- 8.4 Rest of North America Flow Cytometry Market
- 8.4.1 Rest of North America Flow Cytometry Market by Application
- 8.4.2 Rest of North America Flow Cytometry Market by End User
- 8.4.3 Rest of North America Flow Cytometry Market by Technology
- 8.4.4 Rest of North America Flow Cytometry Market by Component
- Chapter 9. Company Profiles
- 9.1 Becton, Dickinson and Company
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Partnerships, Collaborations, and Agreements:
- 9.1.5.2 Acquisition and Mergers:
- 9.1.5.3 Approvals and Trials:
- 9.2 Thermo Fisher Scientific, Inc.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Product Launches and Product Expansions:
- 9.2.5.2 Acquisition and Mergers:
- 9.3 Danaher Corporation
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
- 9.3.5.1 Product Launches and Product Expansions:
- 9.4 Agilent Technologies, Inc.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Product Launches and Product Expansions:
- 9.4.5.2 Acquisition and Mergers:
- 9.5 BioMérieux S.A.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Acquisition and Mergers:
- 9.6 Bio-Rad laboratories, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.7 DiaSorin S.p.A.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.8 Miltenyi Biotech B.V. & Co. KG
- 9.8.1 Company Overview
- 9.9 Sartorius AG
- 9.9.1 Company Overview
- 9.10. Sysmex Corporation
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Regional Analysis
- 9.10.4 Research & Development Expense
- 9.10.5 Recent strategies and developments:
- 9.10.5.1 Product Launches and Product Expansions:
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook